Pearls of Wisdom
FDA issues draft guidance for the Safer Technologies Program for Medical Devices
The U.S. Food and Drug Administration (FDA) issued a draft guidance titled “Safer Technologies Program for Medical Devices.” The guidance, released on September 18, 2019, expands upon the Safer Technologies Program which was originally described within the...
Experienced clinical research professional joins Pearl Pathways
Pearl Pathways announces the hiring of Emily Baumann as a Clinical Research Analyst. Emily brings over four years of experience in global clinical trial project management and medical affairs to the Pearl Pathways Clinical Services team.Emily's expertise...
Don’t Blow Your Big Chance: How to Win with FDA and EMA Regulators – Robert Seevers of Pearl Pathways will speak at RAPS 2019
Session Title: Don’t Blow Your Big Chance: How to Win with FDA and EMA RegulatorsRobert Seevers, Senior Advisor at Pearl Pathways, will speak during this session and participate in the panel discussion as an expert on the topic. Session synopsis: The...
Handling Legacy Products from a GMP and Regulatory Perspective – RAPS 2019 panel will feature Mark Slisz and John Lockwood of Pearl Pathways
Session Title: The Trials and Tribulations of Handling Legacy Products from a GMP and Regulatory PerspectiveJohn Lockwood, Director of RA/QA Services, will serve as the session leader and Mark Slisz, Senior Advisor, will speak as one of the subject matter...
Pearl Pathways exhibiting and presenting at RAPS Regulatory Convergence
Join us at the 2019 RAPS Regulatory Convergence conference in Philadelphia, PA from September 21 - 24, 2019. The annual RAPS Regulatory Convergence conference focuses exclusively on regulatory topics impacting the life science and healthcare industries....